journal article·2021-03

Radioiodinated Persistent Luminescence Nanoplatform for Radiation‐Induced Photodynamic Therapy and Radiotherapy

Qiang Wang, Nian Liu, Zhenyu Hou, Junpeng Shi, Xinhui Su, Xiaolian Sun

Advanced Healthcare Materials· Volume 10· Issue 5
Publisher page

Abstract

Abstract Radionuclide with Cerenkov radiation (CR) can serve as an internal excitation source to activate photosensitizers for photodynamic therapy (PDT) in deep tumor. However, the low efficiency of CR limits its therapeutic efficacy. A 131I labeled zinc tetra(4‐carboxyphenoxy) phthalocyaninate (ZnPcC4) conjugated Cr3+‐doped zinc gallate (ZnGa2O4:Cr3+, ZGCs) nanoplatform (131I‐ZGCs‐ZnPcC4) is developed for radiotherapy (RT) and radiation‐induced PDT. 131I can not only activate ZGCs for long‐lasting luminescence via both Cerenkov luminescence (CL) and ionizing radiation, which further continuously activate photosensitizer ZnPcC4 for PDT, but also can directly kill cancerous cells. This 131I‐ZGCs‐ZnPcC4 exhibits excellent tumor inhibition both in vitro and in vivo. Combining self‐activated PDT and RT, it is believed that the 131I‐ZGCs‐ZnPcC4 can greatly benefit the deep tumor therapy.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Luminescence Properties of Advanced Materials · Photodynamic Therapy Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Nuclear Medicine, Zhongshan Hospital Xiamen University Xiamen 361004 China

State Key Laboratory of Natural Medicines Key Laboratory of Drug Quality Control and Pharmacovigilance Department of Pharmaceutical Analysis China Pharmaceutical University Nanjing 210009 China

Department of Chemistry Technical University of Munich Garching 85747 Germany

Department of Translational Medicine Xiamen Institute of Rare Earth Materials Chinese Academy of Sciences Xiamen 361021 China

Funding

National Key Research and Development Program of China · National Natural Science Foundation of China · China Pharmaceutical University

References (22)

Show source-provided references
1. 10.1038/nrc107110.1038/nrc1071 ↗
2. 10.1039/C6CS00271D10.1039/C6CS00271D ↗
3. 10.1039/C6CS00616G10.1039/C6CS00616G ↗
4. 10.1016/j.biomaterials.2014.01.06810.1016/j.biomaterials.2014.01.068 ↗
5. 10.1038/nm.293310.1038/nm.2933 ↗
6. 10.1021/jacs.6b0539010.1021/jacs.6b05390 ↗
7. 10.1002/adfm.20170749610.1002/adfm.201707496 ↗
8. 10.1063/1.489010510.1063/1.4890105 ↗
9. 10.1002/anie.20190059410.1002/anie.201900594 ↗
10. 10.2967/jnumed.111.09296510.2967/jnumed.111.092965 ↗
11. 10.1038/nnano.2016.30110.1038/nnano.2016.301 ↗
12. 10.1038/nnano.2015.1710.1038/nnano.2015.17 ↗
13. 10.1021/acsami.6b1025510.1021/acsami.6b10255 ↗
14. 10.1021/jacs.8b0937410.1021/jacs.8b09374 ↗
15. 10.1038/nmat390810.1038/nmat3908 ↗
16. 10.1021/jacs.5b0087210.1021/jacs.5b00872 ↗
17. Liu N. · Small · 2020
18. 10.1007/s12274-019-2549-710.1007/s12274-019-2549-7 ↗
19. 10.1007/s12274-017-1910-y10.1007/s12274-017-1910-y ↗
20. 10.1021/cr00052a00210.1021/cr00052a002 ↗
21. 10.1002/adma.20120243310.1002/adma.201202433 ↗
22. 10.1016/j.dyepig.2004.09.01810.1016/j.dyepig.2004.09.018 ↗